|
Volumn 21, Issue 130, 2012, Pages 207-
|
Ranibizumab and retinal vein occlusion (New indication)
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
PLACEBO;
RANIBIZUMAB;
CENTRAL RETINA VEIN OCCLUSION;
CLINICAL PRACTICE;
DISEASE COURSE;
DRUG DOSE COMPARISON;
DRUG EFFICACY;
EYE PAIN;
HEART FAILURE;
HUMAN;
INTRAOCULAR HEMORRHAGE;
INTRAOCULAR PRESSURE;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
RETINA ISCHEMIA;
RETINA MACULA EDEMA;
RETINA VEIN OCCLUSION;
SHORT SURVEY;
SIDE EFFECT;
SINGLE DRUG DOSE;
TRANSIENT ISCHEMIC ATTACK;
TREATMENT DURATION;
TREATMENT INDICATION;
VISUAL ACUITY;
VISUAL IMPAIRMENT;
ANGIOGENESIS INHIBITORS;
ANTIBODIES, MONOCLONAL, HUMANIZED;
DRUG PACKAGING;
HUMANS;
INTRAVITREAL INJECTIONS;
MACULAR EDEMA;
MEDICATION ERRORS;
PATIENT SELECTION;
RETINAL VEIN OCCLUSION;
RISK ASSESSMENT;
RISK FACTORS;
TREATMENT OUTCOME;
VISION DISORDERS;
VISUAL ACUITY;
|
EID: 84867012942
PISSN: 11677422
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
Times cited : (2)
|
References (0)
|